Real-World Evaluation of the Safety and Effectiveness of Apixaban & Rivaroxaban Lead-in Dosing Compared to Parenteral Lead-in Dosing in the Treatment of Venous Thromboembolism: A Multi-Center Retrospective Cohort Study

BACKGROUND: Although parenteral anticoagulation lead-in is not recommended with apixaban and rivaroxaban, parenteral anticoagulation is often used to replace apixaban or rivaroxaban lead-in doses for the initial phase treatment of VTE. Thus, our study compares the safety and effectiveness of lead-in...

Descripción completa

Detalles Bibliográficos
Autores principales: Korayem, Ghazwa B, Alshaya, Omar A, Alnajjar, Nirvana, Alawad, Ahad, Alotaibi, Rand, Bin Sheraim, Nader, Hakami, Fatemah M, Alsudyyes, Ohud S, Alsoghayer, Rahaf H, Alhushan, Lina M, Qudayr, Asma H, Al Yami, Majed S, Almohammed, Omar A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833328/
https://www.ncbi.nlm.nih.gov/pubmed/36644566
http://dx.doi.org/10.2147/IJGM.S392505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833328/
https://www.ncbi.nlm.nih.gov/pubmed/36644566
http://dx.doi.org/10.2147/IJGM.S392505

Ejemplares similares